CML practitioners need dependable, well researched information to help make the best decisions for their CML patients. International therapeutic guidelines on the management of CML based on the latest research and written by leading CML experts provide a reliable and independent source of information.
This section provides access to a selection of relevant international CML guidelines designed to assist you in the management of your CML patients. These guidelines include:
If you have additional information to provide, please contact us at info@cml-foundation.org
Hochhaus A et al. Leukemia 2020;34(4):966-984
Click here to see the 2020 recommendations
Cross NCP et al. Leukemia 2023 Nov;37(11):2150-2167
Click here to see the laboratory recommendations
Click here to view the NCCN Guidelines
(Version 2.2024 - February, 2024)
Click here to view the NCCN Guidelines for Patients
(Version 2023)
NICE Guidance: Asciminib for treating myeloid leukemia after 2 or more tyrosine kinase inhibitors
Published August 2022
Click here to view the full guidance
Click 'Read more' to find more NICE guidances
Chronic Myeloid Leukemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
Hochhaus A et al. Ann Oncol 2017 1;28(suppl_4): iv41-iv51
International pediatric panel recommendations
Management of children and adolescents with chronic myeloid leukemia in blast phase
Sembill S et al. Leukemia, 2023;37:505–517
Click here to view the full publication
Children's Oncology Group CML Working Group
Management of CML in childen and adolescents
Athale U et al. Pediatr Blood Cancer 2019 Sep;66(9):e27827
Click here to view the full publication
English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
